The risk of developing testicular cancer may increase with early and repeated exposure to diagnostic imaging, according to a recent study.
Results of this phase III trial could change the current standard of care for treating nonseminomatous or combined germ cell tumors of the testis.
Investigators report on long-term results of sentinel node (SN) approach in patients with clinical stage I testicular tumors.